v3.26.1
Revenue from contracts with customers
 6 Months Ended
Jun. 30, 2026
Revenue from contracts with customers
NOTE 3 – Revenue from contracts with customers:
Disaggregation of revenue
The following table disaggregates Teva’s revenues by major revenue streams. For additional information on disaggregation of revenues, see note 15.
In alignment with Teva’s Pivot to Growth strategy, commencing January 1, 2026, Anda is no longer reported under Teva’s United States segment. As a result, from that date, Anda is reported as part of the Company’s Other Activities. Prior period amounts were recast to reflect this change.
 
 
  
Three months ended June 30, 2026
 
 
  
United States
 
 
Europe
 
 
International
Markets
 
 
Other
Activities
 
  
Total
 
 
  
(U.S.$ in millions)
 
Sale of goods
      1,704       1,253       527       118        3,602  
Licensing arrangements
      17       13       7       §        37  
Distribution
      —        §       20       413        433  
Other
      (19 )      (3 )      (3 )      95        70  
  
 
 
    
 
 
    
 
 
    
 
 
     
 
 
  
  
$
1,702
 
  
$
1,263
 
  
$
550
 
  
$
627
 
   
$
4,142
 
  
 
 
    
 
 
    
 
 
    
 
 
     
 
 
  
 
§
Represents an amount less than $0.5 million.
 
 
  
Three months ended June 30, 2025
 
 
  
United States
 
  
Europe
 
  
International
Markets
 
  
Other
Activities
 
 
Total
 
 
  
(U.S.$ in millions)
 
Sale of goods
      1,755        1,275        469        136       3,636  
Licensing arrangements
      29        9        9        (1 )      46  
Distribution
      —         §        12        365       377  
Other
      2        13        5        98       117  
  
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
  
$
1,786
 
   
$
1,298
 
   
$
495
 
   
$
597
 
  
$
4,176
 
  
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
 
§
Represents an amount less than $0.5 million.
 
 
  
Six months ended June 30, 2026
 
 
  
United States
 
  
Europe
 
  
International
Markets
 
  
Other
Activities
 
  
Total
 
 
  
(U.S.$ in millions)
 
Sale of goods
      3,197        2,565        1,003        227        6,991  
Licensing arrangements
      39        23        15        §        77  
Distribution
      —         §        38        792        830  
Other
      1        15        18        192        226  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
  
$
3,236
 
   
$
2,603
 
   
$
1,074
 
   
$
1,211
 
   
$
8,124
 
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
 
§
Represents an amount less than $0.5 million.
 
    
Six months ended June 30, 2025
  
    
United States
     
Europe
     
International
Markets
     
Other
Activities
     
Total
  
    
(U.S.$ in millions)
  
Sale of goods
      3,270        2,473        1,023        265        7,031  
Licensing arrangements
      50        16        16        §        82  
Distribution
      —         §        22        738        760  
Other
      2        2        17        173        194  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
  
$
3,322
 
   
$
2,492
 
   
$
1,077
 
   
$
1,176
 
   
$
8,067
 
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
 
§
Represents an amount less than $0.5 million.
Variable consideration
Variable consideration mainly includes sales reserves and allowances
(“SR&A”), comprised of rebates (including Medicaid and other governmental program discounts), chargebacks, returns and other promotional (in
cluding shelf stock adjustments) items. Provisions for prompt payment discounts are netted against accounts receivables.
The Company recognizes these provisions
at
the time of sale and adjusts them if the actual amounts differ from the estimated provisions.
SR&A to U.
S. customers comprised approximately 69% of the Company’s total SR&A as of June 30, 2026, with the remaining balance primarily related to customers in Canada and Germany. The changes in SR&A for third-party sales for the six months ended June 30, 2026 and 2025 were as follows:
 
 
  
Sales Reserves and Allowances
 
 
 
 
 
  
Reserves
included in
Accounts
Receivable,
net
 
 
Rebates
 
 
Medicaid and
other
governmental
allowances
 
 
Chargebacks
 
 
Returns
 
 
Other
 
 
Total
reserves
included in
Sales
Reserves
and
Allowances
 
 
Total
 
 
  
(U.S.$ in millions)
 
Balance at January 1, 2026
    $ 63      $ 1,954      $ 701      $ 937      $ 445      $ 106      $ 4,143      $ 4,206  
Provisions related to sales made in current year
period
    186    2,387    596    3,877    130    71      7,061        7,247  
Provisions related to sales made in prior periods
    —     (47
)
    (54
)
    (10
)
 
    (12
)
    (5
)
 
      (128 )
  (128 )
Credits and payments
    (190
)
 
    (2,475
)
 
    (566
)
 
    (3,897
)
 
    (153
)
 
    (59
)
 
      (7,150 )      (7,340 )
Translation differences
    —     (19
)
    (2
)
    (4
)
    (1
)
    (1
)
      (27 )      (27 )
 
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
Balance at June 30, 2026
    $ 59      $ 1,800      $ 675      $ 903      $ 409      $ 112      $ 3,899      $ 3,958  
  
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
 
    
Sales Reserves and Allowances
        
    
Reserves
included in
Accounts
Receivable,
net
    
Rebates
    
Medicaid and
other
governmental
allowances
    
Chargebacks
    
Returns
    
Other
    
Total
reserves
included in
Sales
Reserves
and
Allowances
    
Total
  
    
(U.S.$ in millions)
  
Balance at January 1, 2025
    $ 56     $ 1,674     $ 561     $ 936     $ 399     $ 108     $ 3,678     $ 3,734  
Provisions related to sales made in current year period
      203       2,520       486       4,034       143       73       7,256       7,459  
Provisions related to sales made in prior periods
      —        (46 )      30       (28 )      (1 )      (7 )      (52 )      (52 ) 
Credits and payments
      (194 )      (2,363 )      (468 )      (3,962 )      (112 )      (48 )      (6,953 )      (7,147 ) 
Translation differences
      —        64       17       18       5       17       121       121  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
  
Balance at June 30, 2025
    $ 65     $ 1,849     $ 626     $ 998     $ 434     $ 143     $ 4,050     $ 4,115